Status:
RECRUITING
French National Cohort of Patients With PRSS1 Mutations
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hereditary Pancreatitis
PRSS1 Gene Mutation
Eligibility:
All Genders
Brief Summary
The diagnosis of hereditary pancreatitis (PH) is based on a genetic criterion - detection of a mutation in the PRSS1 gene or on a genealogical criterion - the presence of chronic pancreatitis in at le...
Detailed Description
The diagnosis of hereditary pancreatitis (HP) is based on a genetic criterion - identification of a mutation in the PRSS1 gene - or a genealogical criterion - the presence of chronic pancreatitis in a...
Eligibility Criteria
Inclusion
- Being a carrier of a known genetic mutation in the PRSS1 gene coding for cationic trypsinogen
- Be followed in one of the participating centers
Exclusion
- Opposition to data collection, expressed by the patient or one of their legal representatives
Key Trial Info
Start Date :
November 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2044
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT07413029
Start Date
November 10 2024
End Date
December 31 2044
Last Update
February 17 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
REBOURS
Clichy-sous-Bois, France